Condition: Arthritis, Psoriatic · Sponsor: Johnson & Johnson Private Limited
The purpose of this study is to evaluate the safety and how well guselkumab treatment works (efficacy) in participants with psoriatic arthritis (PsA; a chronic, autoimmune form of arthritis that causes joint inflammation) who had inadequate response to standard therapies.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Cims Hospital | Ahmedabad, India | Recruiting |
| Post Graduate Institute of Medical Education And Research PGIMER | Chandigarh, India | Recruiting |
| Chennai Meenakshi Multispeciality Hospital | Chennai, India | Recruiting |
| All India Institute of Medical Sciences 1 | Gorakhpur, India | Recruiting |
| Nizams Institute of Medical Sciences | Hyderabad, India | Recruiting |
| P. D. Hinduja National Hospital and Research Center | Mumbai, India | Recruiting |
| All India Institute of Medical Sciences | New Delhi, India | Recruiting |
| Sir Ganga Ram Hospital | New Delhi, India | Recruiting |
| All India Institute of Medical Sciences | Patna, India | Recruiting |
| Jehangir Clinical Development Centre | Pune, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07141004